Advertisement

PharmacoEconomics & Outcomes News

, Volume 819, Issue 1, pp 37–37 | Cite as

NICE recommends benralizumab for severe eosinophilic asthma

News item
  • 6 Downloads

Reference

  1. NICE. Third biological treatment gives more choice for people with severe asthma. Internet Document : 4 Jan 2019. Available from: URL: https://www.nice.org.uk/news/article/third-biological-treatment-gives-more-choice-for-severe-asthma-sufferers

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations